5α-reductase inhibitors and the risk of grade reclassification for men with long-term follow-up on active surveillance for prostate cancer.

被引：0
|
作者：
Finelli, Antonio
Timilshina, Narhari
Komisarenko, Maria
Sowerby, Robert
Hamilton, Robert James
Zlotta, Alexandre
Fleshner, Neil Eric
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Toronto, Brampton, ON, Canada
[3] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg Oncol, Toronto, ON, Canada
[4] Princess Margaret Canc Ctr, Toronto, ON, Canada
[5] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 02期
关键词：
D O I：
10.1200/jco.2016.34.2_suppl.92
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
92
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prostate cancer adverse pathology reclassification in patients undergoing active surveillance in a long-term follow-up series
    Fernandez-Conejo, Guillermo
    Hernandez, Virginia
    Guijarro, Ana
    de la Pena, Enrique
    Ines, Alberto
    Perez-Fernandez, Elia
    Llorente, Carlos
    PROSTATE, 2020, 80 (02): : 209 - 213
  • [2] Five-alpha reductase inhibitors in men undergoing active surveillance for prostate cancer: impact on treatment and reclassification after 6 years follow-up
    Akbar N. Ashrafi
    Toshitaka Shin
    Arnaud Marien
    Thomas Clifford
    Sunao Shoji
    Tsuyoshi Iwata
    Atsuko Iwata
    Masakatsu Oishi
    Sameer Chopra
    Jie Cai
    Osamu Ukimura
    Duke Bahn
    Inderbir S. Gill
    Andre Luis Abreu
    World Journal of Urology, 2021, 39 : 3295 - 3307
  • [3] Five-alpha reductase inhibitors in men undergoing active surveillance for prostate cancer: impact on treatment and reclassification after 6 years follow-up
    Ashrafi, Akbar N.
    Shin, Toshitaka
    Marien, Arnaud
    Clifford, Thomas
    Shoji, Sunao
    Iwata, Tsuyoshi
    Iwata, Atsuko
    Oishi, Masakatsu
    Chopra, Sameer
    Cai, Jie
    Ukimura, Osamu
    Bahn, Duke
    Gill, Inderbir S.
    Abreu, Andre Luis
    WORLD JOURNAL OF UROLOGY, 2021, 39 (09) : 3295 - 3307
  • [4] Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer
    Finelli, A.
    Komisarenko, M.
    Martin, L. J.
    Timilshina, N.
    Jain, K.
    Morris, J.
    Zlotta, A.
    Kulkarni, G.
    Perlis, N.
    van der Kwast, T.
    Evans, A.
    Ghai, S.
    Fleshner, N.
    Alibhai, S. M. H.
    Hamilton, R. J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (01) : 69 - 76
  • [5] Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer
    A. Finelli
    M. Komisarenko
    L. J. Martin
    N. Timilshina
    K. Jain
    J. Morris
    A. Zlotta
    G. Kulkarni
    N. Perlis
    T. van der Kwast
    A. Evans
    S. Ghai
    N. Fleshner
    S. M. H. Alibhai
    R. J. Hamilton
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 69 - 76
  • [6] Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
    Klotz, Laurence
    Vesprini, Danny
    Sethukavalan, Perakaa
    Jethava, Vibhuti
    Zhang, Liying
    Jain, Suneil
    Yamamoto, Toshihiro
    Mamedov, Alexandre
    Loblaw, Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03) : 272 - U75
  • [7] Re: Long-term Follow-up of a Large Active Surveillance Cohort of Patients with Prostate Cancer
    Loeb, Stacy
    EUROPEAN UROLOGY, 2015, 68 (05) : 907 - 907
  • [8] LONG-TERM RISK OF METASTATIC PROSTATE CANCER IN MEN WITH GRADE GROUP 2 MANAGED WITH ACTIVE SURVEILLANCE
    Carlsson, Sigrid
    Benfante, Nicole
    Alvim, Ricardo
    Sjoberg, Daniel D.
    Ehdaie, Behfar
    Scardino, Peter
    Eastham, James
    Touijer, Karim
    JOURNAL OF UROLOGY, 2018, 199 (04): : E137 - E137
  • [9] Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable Features
    Dai, Charles
    Ganesan, Vishnu
    Zabell, Joseph
    Nyame, Yaw A.
    Almassi, Nima
    Greene, Daniel J.
    Hettel, Daniel
    Reichard, Chad
    Haywood, Samuel C.
    Arora, Hans
    Zampini, Anna
    Crane, Alice
    Li, Jianbo
    Elshafei, Ahmed
    Magi-Galluzzi, Cristina
    Stein, Robert J.
    Fareed, Khaled
    Gong, Michael
    Jones, J. Stephen
    Klein, Eric A.
    Stephenson, Andrew J.
    JOURNAL OF UROLOGY, 2018, 199 (02): : 445 - 452
  • [10] Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
    Klotz, Laurence
    Zhang, Liying
    Lam, Adam
    Nam, Robert
    Mamedov, Alexandre
    Loblaw, Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 126 - 131
12345